Research and Development

Showing 15 posts of 9596 posts found.

Genzyme buys SangStat for $600m

October 29, 2003 Research and Development

US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …

Pre-clinical marketing: understanding need

October 29, 2003 Research and Development marketing, pre-clinical

Since the modern pharmaceutical industry emerged, product development has been largely driven by science, with R&D seen almost exclusively as …

GSK pipeline fuelled by purchases

October 29, 2003 Research and Development

GlaxoSmithKline leads the industry in licensing in new drugs, buying the rights to nearly twice as many products as its …

Trial failure forces Xenova cutbacks

October 28, 2003 Research and Development

Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about …

UK research centre falls victim to Pfizer merger

October 28, 2003 Research and Development

A leading UK drug discovery centre is one of a number of global sites to close following Pfizer's recently completed …

Roche’s targeted cancer drug fails

October 28, 2003 Research and Development

A new type of cancer drug developed by Roche, Genentech and OSI Pharmaceuticals has failed to prove its efficacy in …

New data boosts AstraZeneca’s Atacand

October 28, 2003 Research and Development, Sales and Marketing

New trial data on AstraZeneca's blood pressure treatment Atacand could give the drug a lead over rivals in the same …

Why can’t pharma be more like this?

October 24, 2003 Research and Development, Sales and Marketing branding, corporate

Brands are compressed bytes of information. They contain myriad messages that create impressions. If these impressions net out in a …
The Gateway to Local Adoption Series

Latest content